Agilent director sells 634 shares at $151.38

Agilent director Mikael Dolsten sold 634 common shares and now directly holds about 4.9 thousand shares, including deferred dividend-reinvestment shares.

Rhea-AI Filing Summary

AGILENT TECHNOLOGIES, INC. (A) director Mikael Dolsten reported selling 634 shares of common stock on September 4, 2026, in an open-market or private transaction at $151.375 per share. After this sale, he held 4,923.680 shares directly, including 9.295 shares acquired through a dividend reinvestment plan and deferred. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Seller: 634 shares

Net Sell 1 txn

Insider Dolsten Mikael

Role Director

Sold 634 shs ($96K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	634	$151.375	$96K

Holdings After Transaction: Common Stock — 4,923.68 shares (Direct)

Footnotes (1)

1. F1. Includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock.

Key Figures

Shares sold: 634 shares Sale price per share: $151.375 per share Shares held after transaction: 4,923.680 shares +1 more

4 metrics

Shares sold 634 shares Common stock sale reported for September 4, 2026

Sale price per share $151.375 per share Price for the 634 common shares sold on September 4, 2026

Shares held after transaction 4,923.680 shares Direct ownership of Agilent common stock following the reported sale

Dividend reinvestment plan shares 9.295 shares Portion of post-transaction holdings acquired via dividend reinvestment and deferred

Key Terms

dividend reinvestment plan, Rule 16a-11, deferred

3 terms

dividend reinvestment plan financial

"Includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan"

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

Rule 16a-11 regulatory

"transactions exempt under Rule 16a-11"

deferred financial

"The reporting person has elected to defer these shares of common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Agilent (A) director Mikael Dolsten report?

Mikael Dolsten reported a sale of 634 shares of Agilent common stock on September 4, 2026, in a transaction classified as an open-market or private sale.

At what price were the Agilent (A) shares sold by Mikael Dolsten?

The 634 Agilent common shares were sold at a price of $151.375 per share, as reported in the Form 4 filing.

How many Agilent (A) shares does Mikael Dolsten hold after this transaction?

Following the sale, Mikael Dolsten directly holds 4,923.680 shares of Agilent common stock, according to the filing’s post-transaction ownership figure.

Does Mikael Dolsten’s Agilent (A) holding include dividend reinvestment plan shares?

Yes. His post-transaction holdings include 9.295 shares acquired under the Agilent dividend reinvestment plan, which the filing states are deferred.

Was Mikael Dolsten’s Agilent (A) stock sale under a Rule 10b5-1 trading plan?

The filing indicates no Rule 10b5-1 trading plan for this transaction, as the plan-related checkbox is not marked and no footnote describes a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 04:02 PM EDT Accepted by SEC EDGAR 09/09/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolsten Mikael

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		S		634	D	$151.375	4,923.68(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 9.295 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan in transactions exempt under Rule 16a-11. The reporting person has elected to defer these shares of common stock.

	/s/ Shirley Qin, attorney-in-fact for Mr. Dolsten	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)